Royal Philips (NYSE:PHG) announced that it received FDA 510(k) clearance for its latest Philips Capsule Surveillance system.
Amsterdam-based Philips designed its Philips Capsule Surveillance solution to aggregate patient data, analyze the data to generate actionable insights and alerts and send timely notifications to caregivers so they can intervene before any patient deterioration progresses further.
The company said in a news release that the latest release includes expanded interoperability into hospitals’ existing mobile clinical communication and collaboration tools, as well as electronic intensive care units and virtual care population health management systems. Philips said this design offers more visibility on live streaming data, waveforms, device alarms and contextual alerts.
Philips Capsule Surveillance allows clinicians to see patient data and patient monitor settings and alarms from multiple device types without needing to enter a patient’s room. This can help reduce the risk of infection for clinical staff caring for infectious patients, while early identification of deteriorating patient conditions can help to avoid complications and escalations, which contributes to lower cost of care and more efficient uses of resources.
The company plans to release the latest version of the Philips Capsule Surveillance in the second quarter of 2022 to limited sites in the U.S.
“This FDA clearance of the latest release of clinical surveillance solution enables more integrated viewing options within EMR and HIT tools through the secure web-based user interface,” Philips GM of Clinical Data Services Elad Benjamin said in the release. “Properly implemented clinical surveillance has the potential to significantly improve patient outcomes by helping to avoid deterioration, while also improving the care team experience via clinical decision support and minimizing the burden of false and clinically unactionable alarms.”
News of Philips Capsule Surveillance System’s FDA clearance comes on the heels of the company announcing a range of analytics and interoperability offerings at the 2022 HIMSS Global Health Conference and Exhibition.
The company acquired Capsule Technologies for $635 million last year in an effort to enhance its cloud-based digital health platform. Philips Virtual Care Solutions Business Category Leader Christine Storm and Informatics Transformational Programs Leader Bas Kuppens recently explained how the cloud has changed medtech and what’s coming in the future to Medical Design & Outsourcing.
